Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;15(3):339-348.
doi: 10.1016/j.cgh.2016.08.007. Epub 2016 Aug 12.

Suspected Nonceliac Gluten Sensitivity Confirmed in Few Patients After Gluten Challenge in Double-Blind, Placebo-Controlled Trials

Affiliations

Suspected Nonceliac Gluten Sensitivity Confirmed in Few Patients After Gluten Challenge in Double-Blind, Placebo-Controlled Trials

Javier Molina-Infante et al. Clin Gastroenterol Hepatol. 2017 Mar.

Abstract

A double-blind, placebo-controlled, gluten challenge has been proposed to confirm a diagnosis of nonceliac gluten sensitivity (NCGS) in patients without celiac disease who respond to a gluten-free diet. To determine the accuracy of this approach, we analyzed data from 10 double-blind, placebo-controlled, gluten-challenge trials, comprising 1312 adults. The studies varied in the duration of the challenge (range, 1 d to 6 wk), daily doses for the gluten challenge (range, 2-52 g; 3 studies administered <8 g/d), and composition of the placebo (gluten-free products, xylose, whey protein, rice, or corn starch containing fermentable carbohydrates). Most of the studies found gluten challenge to significantly increase symptom scores compared with placebo. However, only 38 of 231 NCGS patients (16%) showed gluten-specific symptoms. Furthermore, 40% of these subjects had a nocebo response (similar or increased symptoms in response to placebo). These findings reveal heterogeneity and potential methodology flaws among studies of gluten challenge, cast doubt on gluten as the culprit food component in most patients with presumptive NCGS, and highlight the importance of the nocebo effect in these types of studies.

Keywords: Celiac Disease; Gluten-Free Diet; Irritable Bowel Syndrome; Wheat Allergy.

PubMed Disclaimer

Comment in

  • JPEN Journal Club 37. Placebos and Nocebos.
    Koretz RL. Koretz RL. JPEN J Parenter Enteral Nutr. 2018 Sep;42(7):1211-1213. doi: 10.1002/jpen.1429. Epub 2018 Aug 17. JPEN J Parenter Enteral Nutr. 2018. PMID: 30117536 No abstract available.

Similar articles

Cited by

MeSH terms

LinkOut - more resources

  NODES
admin 2
INTERN 2
twitter 2